Senior Research Scientist: Cellular assay development

Senior Research Scientist: Cellular assay development

Arbetsbeskrivning

At AstraZeneca we work together across global boundaries to make an impact and find answers to challenges. We do this with integrity even in difficult situations because we are committed to doing the right thing. We continuously pursue world-class medicines in new ways, combining our people’s exceptional skills with those of people from all over the globe.


About the position
As a Senior Research Scientist in cellular assay development in Gothenburg, Sweden, you’ll play a pivotal role in channeling our scientific capabilities to make a positive impact on changing patients’ lives. You will work within Discovery Sciences, part of AstraZeneca’s BioPharmaceuticals organisation, which focuses on scientific advances in drug discovery across therapeutic areas including, respiratory and inflammation (R&I) and cardiovascular and metabolism (CVRM).
We have an exciting opportunity for you to join us as a lab-based scientist to develop state-of-the-art cell-based screening assays. These assays will be used to support discovery of therapeutic peptides and oligonucleotides in AstraZeneca’s drug discovery pipeline.
To be successful in the role as Senior Research Scientist we believe you are a highly motivated scientist with a passion to make a difference for patients. We see you as a person who enjoys collaboration and team working, who holds networking skills with experience of interacting effectively across interfaces of functions, disciplines, and cultures. This goes hand in hand with strong delivery focus, problem-solving and communication skills.


Your profile
• PhD in Biology, Pharmacology, Cell biology or a related discipline or a BSc/MSc degree with significant relevant experience, preferably in the pharmaceutical or biotechnology industry
• Strong experience in cell biology techniques applied to development of physiologically relevant cellular assays
• A practical understanding of a wide range of cellular assay methods and technologies including qPCR and imaging applied to compound profiling and screening
• Excellent communication skills and an ability to operate effectively in a multi-disciplinary research environment
• Ability to independently analyse and evaluate complex data and deliver data to agreed timelines

Desirable Requirements
• Expertise in the design, development and validation of cellular assays for compound screening and profiling, including peptides and oligonucleotides
• Experience with automation of cell assays, e.g. work with liquid handlers like Echo, BRAVO, CyBi well or Dragonfly
• Experience with design of experiments and statistical analysis of assay performance
• Track record of identifying and adopting scientific and technical advances
• Excellent problem-solving skills, not limited to own area of expertise

About the organisation
This position is a consultant assignment at AstraZeneca via QRIOS Life Science & Engineering in Göteborg for one year. During this time you will be employed by QRIOS Life Science & Engineering.
QRIOS employs curious experts in IT, Life Science and Engineering. We want to continue to attract the best employees, to continue to support our partners with the important competences you require. We are a recruitment and consulting company that is strongly inspired by those who never stop looking for new solutions. As we say, QRIOS MINDS GO FURTHER

Why AstraZeneca?
Our Gothenburg site is one of AstraZeneca's three strategic R&D centers. With more than 2,400 employees from over than 50 countries, our vibrant Gothenburg site is a truly inspiring place to work. Here, the history and future of scientific breakthrough come together. We believe that the diversity of our people is crucial to bringing new discoveries to life.

Sammanfattning

Liknande jobb


Bioinformatics Research Scientist

Bioinformatics Research Scientist

19 december 2024

18 december 2024

Postdoktor inom stamcellsbaserade modeller av schizofreni

Postdoktor inom stamcellsbaserade modeller av schizofreni

16 december 2024

13 december 2024